NO983508L - Antiglukortikoidmedikament - Google Patents

Antiglukortikoidmedikament

Info

Publication number: NO983508L
Authority: NO; Norway
Prior art keywords: aliphatic; pheromones; drugs; mammalian cells; carbon atoms
Prior art date: 1996-01-31

Application number

NO983508A

Other languages

English (en)

Norwegian (no)

Other versions

NO983508D0 (no

Inventor

Sergei Dmitrievich Burlakov

Dmitry Dmitrievich Genkin

Kirill Gennadievich Surkov

Viktor Veniaminovich Tets

Original Assignee

Sergei Dmitrievich Burlakov

Dmitry Dmitrievich Genkin

Kirill Gennadievich Surkov

Viktor Veniaminovich Tets

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-31

Filing date

1998-07-30

Publication date

1998-07-30

1998-07-30 Application filed by Sergei Dmitrievich Burlakov, Dmitry Dmitrievich Genkin, Kirill Gennadievich Surkov, Viktor Veniaminovich Tets filed Critical Sergei Dmitrievich Burlakov

1998-07-30 Publication of NO983508D0 publication Critical patent/NO983508D0/no

1998-07-30 Publication of NO983508L publication Critical patent/NO983508L/no

Links

230000000694 effects Effects 0.000 abstract 3
239000003016 pheromone Substances 0.000 abstract 3
125000004432 carbon atom Chemical group C* 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003862 glucocorticoid Substances 0.000 abstract 2
239000005556 hormone Substances 0.000 abstract 2
229940088597 hormone Drugs 0.000 abstract 2
210000004962 mammalian cell Anatomy 0.000 abstract 2
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical class C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
241000238631 Hexapoda Species 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
231100000053 low toxicity Toxicity 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001105 regulatory effect Effects 0.000 abstract 1
230000035945 sensitivity Effects 0.000 abstract 1
230000003637 steroidlike Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Securing Of Glass Panes Or The Like (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

NO983508A 1996-01-31 1998-07-30 Antiglukortikoidmedikament NO983508L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
RU96101194/14A RU2125446C1 (ru)	1996-01-31	1996-01-31	Антиглюкокортикоидное лекарственное средство
PCT/RU1996/000028 WO1997027845A1 (en)	1996-01-31	1996-02-01	Antiglucocorticoid drug

Publications (2)

Publication Number	Publication Date
NO983508D0 NO983508D0 (no)	1998-07-30
NO983508L true NO983508L (no)	1998-07-30

Family

ID=20175968

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO983508A NO983508L (no)	1996-01-31	1998-07-30	Antiglukortikoidmedikament

Country Status (24)

Country	Link
US (1)	US5965623A (lt)
EP (1)	EP0896819A4 (lt)
JP (1)	JPH11504946A (lt)
KR (1)	KR100347862B1 (lt)
CN (1)	CN1213964A (lt)
AU (1)	AU710479B2 (lt)
BG (1)	BG102709A (lt)
BR (1)	BR9612470A (lt)
CA (1)	CA2244985A1 (lt)
CZ (1)	CZ160598A3 (lt)
EE (1)	EE9800209A (lt)
GE (1)	GEP20001955B (lt)
HU (1)	HUP9900504A2 (lt)
LT (1)	LT4441B (lt)
LV (1)	LV12177B (lt)
MD (1)	MD1430B1 (lt)
MX (1)	MX9806182A (lt)
NO (1)	NO983508L (lt)
PL (1)	PL187564B1 (lt)
RU (1)	RU2125446C1 (lt)
SI (1)	SI9620053A (lt)
SK (1)	SK65598A3 (lt)
UA (1)	UA48212C2 (lt)
WO (1)	WO1997027845A1 (lt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU1929401A (en) *	1999-12-01	2001-06-12	Alydar Pharmaceuticals Ltd.	Method for screening non-peptide, non-steroid inverterbrate pheromones, compositions containing the same and use of the compositions to treat diseases, conditions, and symptoms thereof
US6548706B2 (en) *	1999-12-23	2003-04-15	Aerojet Fine Chemicals Llc	Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
US6806293B1 (en)	2001-03-12	2004-10-19	Darley Pharmaceuticals Ltd	Use of pheromone compounds having MAP kinase modulating activity
AU2001243556A1 (en) *	2001-03-12	2002-09-24	Alydar Pharmaceuticals, Inc.	Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity
RU2211213C2 (ru) *	2001-05-16	2003-08-27	Закрытое Акционерное Общество "Асгл - Исследовательские Лаборатории"	Лекарственное средство, обладающее противоязвенным, кардиопротективным и противошоковым действием
US20040018959A1 (en) *	2002-05-02	2004-01-29	Randall S. Hickle	System and methods of lipid removal from the body
RU2222326C1 (ru) *	2002-10-09	2004-01-27	Российский онкологический научный центр им. Н.Н.Блохина РАМН	Способ лечения саркомы юинга
US6752649B2 (en) *	2002-11-07	2004-06-22	Xentris, Llc	Illuminated indicia power supply apparatus and method of manufacture
DE10335845B4 (de) *	2003-05-09	2006-08-31	Müller, Martina, Dr.med.	Pheromone als Antikrebsmittel
KR100556335B1 (ko) *	2004-02-05	2006-03-03	정만길	6알-(3,6-디데옥시-엘-아라비노-헥소피라노실옥시)헵타노익산, 그 제조방법 및 그를 포함하는 장기휴면 유발효과
WO2010017177A1 (en) *	2008-08-06	2010-02-11	The Trustees Of The University Of Pennsylvania	Ultrasonically induced release from polymer vesicles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US161926A (en)		1875-04-13		Improvement in ink-wells
US2900756A (en) *	1958-12-09	1959-08-25	Jacobson Martin	Attractants for the gypsy moth
EP0149847A3 (en) *	1983-12-26	1989-11-08	Eisai Co., Ltd.	Therapeutic and preventive agent containing dolichol
JPH0759504B2 (ja) *	1986-01-23	1995-06-28	エーザイ株式会社	ポリプレニルアルコ−ル含有注射剤
US5019569A (en) *	1986-11-03	1991-05-28	Ortho Pharmaceutical Corporation	Reversal of glucocorticoid-induced skin atrophy
US4740627A (en) *	1987-05-21	1988-04-26	Phillips Petroleum Company	Synthesis of E,Z-11-tetradecen-1-al
ATE80313T1 (de)	1988-02-29	1992-09-15	Pfizer	Mittel zur erhoehung des transdermalen penetrationsflusses.
US5190978A (en) *	1989-09-29	1993-03-02	Dai-Ichi Kogyo Seiyaku Co. Ltd.	Carcinostatic compositions and methods
FR2718354B1 (fr) *	1994-04-08	1996-05-03	Roussel Uclaf	Application des composés antiglucocorticoïde pour la préparation de médicaments destinés à la prévention ou au traitement des manifestations liées au syndrome de sevrage des narcotiques et les compositions les renfermant.

1996
- 1996-01-02 UA UA98074187A patent/UA48212C2/uk unknown
- 1996-01-31 RU RU96101194/14A patent/RU2125446C1/ru not_active IP Right Cessation
- 1996-02-01 CN CN96180161A patent/CN1213964A/zh active Pending
- 1996-02-01 JP JP9527525A patent/JPH11504946A/ja active Pending
- 1996-02-01 EP EP96902026A patent/EP0896819A4/en not_active Withdrawn
- 1996-02-01 SK SK655-98A patent/SK65598A3/sk unknown
- 1996-02-01 AU AU46363/96A patent/AU710479B2/en not_active Ceased
- 1996-02-01 EE EE9800209A patent/EE9800209A/xx unknown
- 1996-02-01 GE GEAP19964288A patent/GEP20001955B/en unknown
- 1996-02-01 MD MD98-0171A patent/MD1430B1/ro unknown
- 1996-02-01 BR BR9612470A patent/BR9612470A/pt not_active Application Discontinuation
- 1996-02-01 SI SI9620053A patent/SI9620053A/sl not_active IP Right Cessation
- 1996-02-01 WO PCT/RU1996/000028 patent/WO1997027845A1/ru not_active Ceased
- 1996-02-01 HU HU9900504A patent/HUP9900504A2/hu unknown
- 1996-02-01 PL PL96322596A patent/PL187564B1/pl unknown
- 1996-02-01 CA CA002244985A patent/CA2244985A1/en not_active Abandoned
- 1996-02-01 US US08/930,733 patent/US5965623A/en not_active Expired - Fee Related
- 1996-02-01 KR KR10-1998-0705074A patent/KR100347862B1/ko not_active Expired - Fee Related
- 1996-02-01 CZ CZ981605A patent/CZ160598A3/cs unknown
1998
- 1998-04-21 LT LT98-054A patent/LT4441B/lt not_active IP Right Cessation
- 1998-05-28 LV LVP-98-126A patent/LV12177B/lv unknown
- 1998-07-30 NO NO983508A patent/NO983508L/no unknown
- 1998-07-31 MX MX9806182A patent/MX9806182A/es unknown
- 1998-08-20 BG BG102709A patent/BG102709A/xx unknown

Also Published As

Publication number	Publication date
RU2125446C1 (ru)	1999-01-27
HUP9900504A2 (en)	1999-09-28
EE9800209A (et)	1998-12-15
AU4636396A (en)	1997-08-22
WO1997027845A1 (en)	1997-08-07
NO983508D0 (no)	1998-07-30
KR19990076946A (ko)	1999-10-25
LV12177A (lv)	1998-12-20
LV12177B (lv)	1999-06-20
EP0896819A1 (en)	1999-02-17
MX9806182A (es)	1998-10-31
LT98054A (lt)	1998-10-26
CZ160598A3 (cs)	1998-08-12
LT4441B (lt)	1999-01-25
SK65598A3 (en)	1998-09-09
CN1213964A (zh)	1999-04-14
PL187564B1 (pl)	2004-08-31
EP0896819A4 (en)	2001-11-07
UA48212C2 (uk)	2002-08-15
CA2244985A1 (en)	1997-08-07
GEP20001955B (en)	2000-03-05
JPH11504946A (ja)	1999-05-11
SI9620053A (sl)	1998-04-30
PL322596A1 (en)	1998-02-02
AU710479B2 (en)	1999-09-23
US5965623A (en)	1999-10-12
BG102709A (bg)	1999-06-30
KR100347862B1 (ko)	2003-01-24
MD1430B1 (ro)	2000-03-31
BR9612470A (pt)	1999-07-13

Publication	Publication Date	Title
Neptune Jr et al.	1959	Labile fatty acids of rat diaphragm muscle and their possible role as the major endogenous substrate for maintenance of respiration
NO983508L (no)	1998-07-30	Antiglukortikoidmedikament
Pang et al.	1997	Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages
ES2176502T3 (es)	2002-12-01	Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
KR910018020A (ko)	1991-11-30	프라바스타틴과 피브르산 유도체의 혼합제. 및 이 혼합제를 사용한 이상지혈증 치료 방법
LV12766A (lv)	2001-12-20	Composition of l-dopa esters
DE68913476D1 (de)	1994-04-07	Kosmetisches Präparat.
KR900017590A (ko)	1990-12-19	좌창(Acne)치료방법 및 그 약제 조성물
DE3866408D1 (de)	1992-01-09	Selbstklebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
Nobre et al.	2001	The role of phospholipase A2 and cyclooxygenase in renal toxicity induced by microcystin-LR
McIsaac et al.	1958	New metabolites of serotonin in carcinoid urine
DE59608201D1 (de)	2001-12-20	Spezifische lipidkonjugate von nucleosid-diphosphaten und deren verwendung als arzneimittel
Pedersen et al.	1972	Studies on the energy state of isolated brown adipose tissue mitochondria the cytochrome b complex as a probe of the energy state of the mitochondrial inner membrane
Koraćević et al.	1977	Effect of trypsin, S-adenosylmethionine and ethionine on L-serine sulfhydrase activity
ES2084281T3 (es)	1996-05-01	Composicion para promover el crecimiento del cabello que contiene esteres del acido citrico.
Wood et al.	1977	Effect of di-n-propylacetate and γ-acetylenic GABA on hyperbaric oxygen-induced seizures and GABA metabolism
Batra et al.	1979	Are there cyclic variations in estradiol secretion in the non-pregnant rabbit?
US5753697A (en)	1998-05-19	Method and pharmaceutical compositions containing rosmanol derivatives
Eaton et al.	1953	Virus growth and cellular energy production: effect of substances chemically related to thyroxin on influenza virus.
GB931115A (en)	1963-07-10	Pharmaceutical preparations containing sitosterols
Yamane et al.	1987	Biological activity of antheridic acid, an antheridiogen of Anemia phyllitidis
Kuehl Jr et al.	1975	Estrogen-induced alterations in cyclic nucleotide and prostaglandin levels in target tissue
KR920021157A (ko)	1992-12-18	두릅 나무 근피 추출물에서 혈당강하작용이 있는 유효성분의 분리 및 그 효과
DE59801586D1 (de)	2001-10-31	Zur topischen applikation bestimmte diclofenac-lösung
LU81501A1 (fr)	1979-10-31	Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques